The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Erlotinib (NDC 70771-1521). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Erlotinib Tablets, 25 mg
30 tablets
NDC 70771-1521-3
Rx only
25 mg Label (5624fa69 Eae5 43bf Aa7e 379266edd77f 01)
Erlotinib Tablets, 100 mg
30 tablets
NDC 70771-1522-3
Rx only
100 mg Label (5624fa69 Eae5 43bf Aa7e 379266edd77f 02)
Erlotinib Tablets, 150 mg
30 tablets
NDC 70771-1523-3
Rx only
150 mg Label (5624fa69 Eae5 43bf Aa7e 379266edd77f 03)
* Please review the disclaimer below.
